Latest Share Chat

ValiRx Confirms JV Talks For Non-Core Intellectual Property

Wed, 29th Apr 2020 18:19

(Alliance News) - Biotechnology company ValiRx PLC on Wednesday confirmed joint venture talks for its non-core intellectual property, GeneICE, TRAC and BioFit.

Shares in the company closed 25% higher at 7.49 pence each in London.

"The company confirms that it is in talks with a third-party in relation to a joint venture. However, there is no certainty the talks will conclude in a successful manner, nor that in the event that the Joint Venture is agreed, that the terms will be favourable to the company," ValiRx said in a statement.

By Tapan Panchal; tapanpanchal@alliancenews.com

Related Shares

More News

20 May 2024 16:52

LONDON MARKET CLOSE: London gets boost thanks to rate cut hopes

(Alliance News) - Stock prices in London closed higher on Monday, with investors optimistic that interest rate cuts might be around the corner.

20 May 2024 14:21

ValiRx shares jump as Cytolytix gets Knowledge Transfer Voucher grant

(Alliance News) - ValiRx PLC on Monday noted that the peptide nanoparticle formation Cytolytix received a Knowledge Transfer Voucher grant in conjunct...

16 May 2024 16:29

EARNINGS AND TRADING: Tullow Oil on track to hit free cash flow target

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

15 May 2024 18:38

TRADING UPDATES: Vertu Motors ups dividend as hails record revenue

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

15 May 2024 10:45

AIM WINNERS & LOSERS: Itim up on Majestic Wine contract renewal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.